CWS yields 0.33% · PFE yields 6.20%● Live data
📍 PFE pulled ahead of the other in Year 8
Combined, CWS + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CWS + PFE for your $10,000?
Complement to any Broad-Based Index Fund — CWS’s strategy seeks to avoid the fundamentally weak companies that index-based funds generally hold and only invest in those perceived as “first in class” firms. Low Turnover — CWS’s strategy is focused on the long term. That’s why CWS aims for a buy-and-hold strategy, trading as infrequently as possible and holding for as long as it can. CWS believes that a disciplined buy-and-hold strategy is ideal for riding out market storms. Innovative Fulcrum Fee Structure — CWS’s Portfolio Strategist’s manager fee is directly tied to performance: outperformance is rewarded with a larger management fee; underperformance is penalized with a smaller management fee. Disciplined Alpha Seeking Strategy — CWS is focused on a core group of what we believe are outstanding firms, offering investors a simple way to get instant exposure to a concentrated equity portfolio of companies with proven competitive advantages.
Full CWS Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.